ATE430745T1 - Aza- und polyaza naphthalenyl karboxamide als inhibitoren der hiv-integrase - Google Patents

Aza- und polyaza naphthalenyl karboxamide als inhibitoren der hiv-integrase

Info

Publication number
ATE430745T1
ATE430745T1 AT01979582T AT01979582T ATE430745T1 AT E430745 T1 ATE430745 T1 AT E430745T1 AT 01979582 T AT01979582 T AT 01979582T AT 01979582 T AT01979582 T AT 01979582T AT E430745 T1 ATE430745 T1 AT E430745T1
Authority
AT
Austria
Prior art keywords
polyaza
aza
inhibitors
hiv integrase
naphthalenyl
Prior art date
Application number
AT01979582T
Other languages
English (en)
Inventor
Neville Anthony
Robert Gomez
Steven Young
Melissa Egbertson
John Wai
Linghang Zhuang
Mark Embrey
Lekhanh Tran
Jeffrey Melamed
H Langford
James Guare
Thorsten FISHER
Samson JOLLY
Michelle KUO
Debra Perlow
Jennifer Bennett
Timothy FUNK
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE430745T1 publication Critical patent/ATE430745T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT01979582T 2000-10-12 2001-10-09 Aza- und polyaza naphthalenyl karboxamide als inhibitoren der hiv-integrase ATE430745T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23970700P 2000-10-12 2000-10-12
US28165601P 2001-04-05 2001-04-05
PCT/US2001/031456 WO2002030930A2 (en) 2000-10-12 2001-10-09 Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors

Publications (1)

Publication Number Publication Date
ATE430745T1 true ATE430745T1 (de) 2009-05-15

Family

ID=26932782

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01979582T ATE430745T1 (de) 2000-10-12 2001-10-09 Aza- und polyaza naphthalenyl karboxamide als inhibitoren der hiv-integrase

Country Status (26)

Country Link
US (2) US6921759B2 (de)
EP (1) EP1326865B1 (de)
JP (1) JP4252797B2 (de)
KR (1) KR20030036922A (de)
CN (1) CN1469878A (de)
AR (1) AR033845A1 (de)
AT (1) ATE430745T1 (de)
AU (3) AU1152702A (de)
BG (1) BG107677A (de)
BR (1) BR0114610A (de)
CA (1) CA2425440C (de)
CZ (1) CZ20031028A3 (de)
DE (1) DE60138635D1 (de)
EA (1) EA200300449A1 (de)
EE (1) EE200300145A (de)
HU (1) HUP0302367A2 (de)
IL (1) IL155089A0 (de)
IS (1) IS6760A (de)
MX (1) MXPA03003263A (de)
NO (1) NO20031672L (de)
NZ (1) NZ525088A (de)
PE (1) PE20020509A1 (de)
PL (1) PL360944A1 (de)
SK (1) SK4322003A3 (de)
WO (2) WO2002030931A2 (de)
YU (1) YU27903A (de)

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE430745T1 (de) * 2000-10-12 2009-05-15 Merck & Co Inc Aza- und polyaza naphthalenyl karboxamide als inhibitoren der hiv-integrase
TWI243164B (en) 2001-02-13 2005-11-11 Aventis Pharma Gmbh Acylated indanyl amines and their use as pharmaceuticals
IL157638A0 (en) * 2001-03-01 2004-03-28 Shionogi & Co Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity
DK3042894T1 (da) 2001-08-10 2016-11-07 Shionogi & Co Antiviralt middel
AR036256A1 (es) * 2001-08-17 2004-08-25 Merck & Co Inc Sal sodica de un inhibidor de integrasa del vih, procesos para su preparacion, composiciones farmaceuticas que lo contienen y su uso para la manufactura de un medicamento
WO2003016294A1 (en) * 2001-08-17 2003-02-27 Merck & Co., Inc. Process for preparing sultams
EP1427726A1 (de) * 2001-08-17 2004-06-16 Merck & Co., Inc. Verfahren zur darstellung von 5-sulfonamido-8-hydroxy-1,6-naphthyridin-7-carboxamiden
DE60209381T2 (de) * 2001-10-26 2006-10-05 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. N-substituierte hydroxypyrimidinoncarboxamid-hemmer der hiv-integrase
SI1441734T1 (sl) 2001-10-26 2007-08-31 Angeletti P Ist Richerche Bio Dihidropirimidin karboksamidni inhibitorji HIV-integraze
DE10155075A1 (de) 2001-11-09 2003-05-22 Merck Patent Gmbh Cyclische Sulfonamide
ES2291642T3 (es) 2002-01-17 2008-03-01 MERCK & CO., INC. Hidroxinaftiridinoncarboxamidas utiles como inhibidores de la integrasa de vih.
AU2003218130A1 (en) 2002-03-15 2003-09-29 Merck And Co., Inc. N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors
US20050165000A1 (en) * 2002-04-10 2005-07-28 Robertson Sandra K. Pharmaceutical compositions containing an hiv integrase inhibitor and a nonionic surfactant
AU2003269878A1 (en) * 2002-05-22 2003-12-22 Smithkline Beecham Corporation Protease inhibitors
EP1388535A1 (de) * 2002-08-07 2004-02-11 Aventis Pharma Deutschland GmbH Acylierte Arylcycloalkylamine und ihre Anwendung als Arzneimittelwirkstoff
DE60322920D1 (de) * 2002-08-13 2008-09-25 Shionogi & Co Heterocyclische verbindungen mit hiv-integrase-hemmender wirkung
US7399763B2 (en) 2002-09-11 2008-07-15 Merck & Co., Inc. 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as HIV integrase inhibitors
US7517532B2 (en) 2002-09-11 2009-04-14 Merck & Co., Inc. Dihydroxypyridopyrazine-1,6-dione compounds useful as HIV integrase inhibitors
EP1558585B1 (de) 2002-10-04 2013-09-25 Prana Biotechnology Limited Neurologisch aktive verbindungen
AU2003284001A1 (en) 2002-10-07 2004-05-04 Bristol-Myers Squibb Company Triazolone and triazolethione derivatives
WO2004035577A2 (en) * 2002-10-16 2004-04-29 Gilead Sciences, Inc. Pre-organized tricyclic integrase inhibitor compounds
BR0317749A (pt) 2002-12-27 2005-11-22 Angeletti P Ist Richerche Bio Composto, composição farmacêutica, e, uso de um composto
WO2004080402A2 (en) * 2003-03-12 2004-09-23 Merck & Co. Inc. Potassium salt of an hiv integrase inhibitor
US20040220273A1 (en) * 2003-03-12 2004-11-04 Jaemoon Lee Preparation of 2-aminomethyl-5-fluorobenzamides
WO2004101512A2 (en) 2003-05-13 2004-11-25 Smithkline Beecham Corporation Naphthyridine integrase inhibitors
CA2532064A1 (en) * 2003-07-15 2005-02-03 Merck & Co., Inc. Hydroxypyridine cgrp receptor antagonists
TW200510425A (en) 2003-08-13 2005-03-16 Japan Tobacco Inc Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor
WO2005028478A1 (en) 2003-09-19 2005-03-31 Gilead Sciences, Inc. Aza-quinolinol phosphonate integrase inhibitor compounds
JP2007509149A (ja) 2003-10-20 2007-04-12 メルク　エンド　カムパニー　インコーポレーテッド Ｈｉｖインテグラーゼ阻害薬として有用なヒドロキシピリドピロロピラジンジオン化合物
TW200533357A (en) 2004-01-08 2005-10-16 Millennium Pharm Inc 2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases
CA2554120A1 (en) * 2004-01-30 2005-08-18 Merck & Co., Inc. N-benzyl-3,4-dihydroxypyridine-2-carboxamide and n-benzyl-2,3-dihydroxypyridine-4-carboxamide compounds useful as hiv integras inhibitors
EP1714966A4 (de) * 2004-02-04 2008-01-02 Shionogi & Co Naphthylidinderivat mit einer hiv-integrase-hemmenden wirkung
EP1720856B1 (de) 2004-02-11 2013-08-14 GlaxoSmithKline LLC Hiv-integrasehemmer
EP1725556A1 (de) * 2004-03-09 2006-11-29 Merck & Co., Inc. Hiv-integrasehemmer
JP2007528396A (ja) * 2004-03-09 2007-10-11 メルク　エンド　カムパニー　インコーポレーテッド Ｈｉｖインテグラーゼ阻害薬
JP2007528394A (ja) * 2004-03-09 2007-10-11 メルク　エンド　カムパニー　インコーポレーテッド Ｈｉｖインテグラーゼ阻害薬
CA2557926A1 (en) 2004-03-09 2005-09-22 Monica Donghi Hiv integrase inhibitors
EP1756114B1 (de) * 2004-05-07 2014-11-19 Merck Sharp & Dohme Corp. Hiv-integrasehemmer
WO2005120516A2 (en) * 2004-06-09 2005-12-22 Merck & Co., Inc. Hiv integrase inhibitors
UA87884C2 (uk) 2004-12-03 2009-08-25 Мерк Энд Ко., Инк. Безводна кристалічна калієва сіль інгібітора віл-інтегрази
MX2007006637A (es) * 2004-12-03 2007-06-19 Merck & Co Inc Uso de atazanavir para mejorar los parametros farmacocineticos de farmacos metabolizados por isoforma 1a1 de udp-glucuronosil- transferasa.
ATE516026T1 (de) * 2005-02-21 2011-07-15 Shionogi & Co Bicyclisches carbamoylpyridonderivat mit hiv- integrase-hemmender wirkung
AU2006228278C1 (en) * 2005-03-31 2011-06-23 Msd Italia S.R.L. HIV integrase inhibitors
CA2607151C (en) * 2005-05-10 2012-06-19 Merck & Co., Inc. Hiv integrase inhibitors
EP1888581A2 (de) * 2005-05-16 2008-02-20 Gilead Sciences, Inc. Hiv-integrasehemmerverbindungen
WO2007019130A2 (en) * 2005-08-04 2007-02-15 Smithkline Beecham Corporation Hiv integrase inhibitors
JP2009503083A (ja) * 2005-08-04 2009-01-29 スミスクライン ビーチャム コーポレーション Ｈｉｖインテグラーゼ阻害薬
US20080194523A1 (en) * 2005-08-04 2008-08-14 Smithkline Beecham Corporation Hiv Integrase Inhibitors
EP1910363A4 (de) * 2005-08-04 2010-05-26 Glaxosmithkline Llc Hiv-integrasehemmer
CA2622639C (en) * 2005-10-04 2012-01-03 Istituto Di Recerche Di Biologia Molecolare P. Angeletti S.P.A. Hiv integrase inhibitors
AU2006307101A1 (en) 2005-10-27 2007-05-03 Shionogi & Co., Ltd. Polycyclic carbamoylpyridone derivative having inhibitory activity on HIV integrase
AU2006306355A1 (en) * 2005-10-27 2007-05-03 Merck & Co., Inc. HIV integrase inhibitors
CN102702194A (zh) * 2005-12-21 2012-10-03 雅培制药有限公司 抗病毒化合物
WO2007136714A2 (en) * 2006-05-16 2007-11-29 Gilead Sciences, Inc. Integrase inhibitors
CA2657287A1 (en) * 2006-07-17 2008-01-24 Merck & Co., Inc. 1-hydroxy naphthyridine compounds as anti-hiv agents
CA2658793A1 (en) * 2006-07-25 2008-02-07 Daniel Dumas Quinoline derivatives
CN101522609A (zh) * 2006-09-05 2009-09-02 彼帕科学公司 癌症的治疗
ES2488922T3 (es) 2006-09-29 2014-09-01 Idenix Pharmaceuticals, Inc. Fosfoindoles enantiómeramente puros como inhibidores del HIV
AU2007313293A1 (en) * 2006-10-18 2008-04-24 Merck & Co., Inc. HIV integrase inhibitors
US20090291921A1 (en) * 2007-11-20 2009-11-26 Gilead Sciences, Inc. Integrase inhibitors
CN101977610B (zh) 2008-01-25 2012-05-16 奇默里克斯公司 治疗病毒感染的方法
CA2730890C (en) 2008-07-17 2018-05-15 Critical Outcome Technologies Inc. Thiosemicarbazone inhibitor compounds and cancer treatment methods
JP2012513464A (ja) 2008-12-23 2012-06-14 ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク ホスホジエステラーゼ阻害剤及びその使用
JP2012528160A (ja) 2009-05-27 2012-11-12 メルク・シャープ・エンド・ドーム・コーポレイション Ｈｉｖプロテアーゼ阻害薬
JP5624148B2 (ja) * 2009-10-13 2014-11-12 エランコ・アニマル・ヘルス・アイルランド・リミテッド 大環状インテグラーゼ阻害剤
ES2898348T3 (es) 2009-10-26 2022-03-07 Merck Sharp & Dohme Composiciones farmacéuticas sólidas que contienen un inhibidor de la integrasa
EP2345643A1 (de) 2009-12-29 2011-07-20 Polichem S.A. Neue tertiäre 8-Hydroxychinolin-7-Carboxamidederivate und deren Verwendungen
EP2345641A1 (de) 2009-12-29 2011-07-20 Polichem S.A. Neue sekundäre 8-Hydroxychinolin-7-Carboxamid-Derivate
EP2345642A1 (de) * 2009-12-29 2011-07-20 Polichem S.A. Sekundäre 8-Hydroxychinolin-7-Carboxamid-Derivate zur Verwendung als Fungizid
PT2534150T (pt) 2010-02-12 2017-05-02 Chimerix Inc Métodos para tratar uma infecção viral
CA2794952C (en) 2010-04-01 2018-05-15 Critical Outcome Technologies Inc. Compounds and method for treatment of hiv
RU2567385C2 (ru) 2010-04-02 2015-11-10 ЯНССЕН Ар ЭНД Ди АЙРЛЭНД Макроциклические ингибиторы интегразы
WO2012055031A1 (en) 2010-10-28 2012-05-03 Merck Canada Inc. Hiv protease inhibitors
EP2661265B1 (de) 2010-12-23 2017-03-08 Merck Sharp & Dohme Corp. Chinoline und aza-chinolines als crth2-rezeptor-modulatoren
ES2635030T3 (es) 2010-12-23 2017-10-02 Merck Sharp & Dohme Corp. Quinoxalinas y aza-quinoxalinas como moduladores del receptor CRTH2
EP2487176A1 (de) * 2011-02-14 2012-08-15 Elanco Animal Health Ireland Limited Makrozyklische Integrasehemmer zur Verwendung bei der Behandlung von felinem Immundefizienz-Virus
CN103547566B (zh) 2011-02-18 2017-05-31 阿萨纳生物科技有限责任公司 氨基茚满化合物及其治疗疼痛的用途
EP2771332B1 (de) 2011-10-26 2016-06-29 Merck Canada Inc. Thiophen- und Thiazol-Sulfonamid-Derivate als HIV Protease Inhibitoren zur Behandlung von AIDS
TWI603957B (zh) 2012-08-15 2017-11-01 阿沙納生物科學有限責任公司 胺基氫茚化合物用於治療膀胱過動症及間質性膀胱炎之用途
BR112015005347A2 (pt) 2012-09-11 2017-08-08 Merck Sharp & Dohme Corp E Merck Canada Inc composto, composição farmacêutica, e, método para tratamento ou profilaxia de infecção por hiv ou para tratamento, profilaxia, ou atraso no início de aids
CN103709162B (zh) * 2012-09-29 2016-12-07 中国科学院上海药物研究所 三取代咪唑并二氮杂萘酮化合物及其制备方法和用途
CN104003986B (zh) * 2013-02-22 2016-06-08 中国科学院上海药物研究所 吡啶骈环类化合物及其制备方法、其药物组合物和用途
WO2015013835A1 (en) 2013-07-31 2015-02-05 Merck Sharp & Dohme Corp. Piperazine derivatives as hiv protease inhibitors
WO2015095265A1 (en) 2013-12-19 2015-06-25 Merck Sharp & Dohme Corp. Hiv protease inhibitors
WO2015095276A1 (en) 2013-12-19 2015-06-25 Merck Sharp & Dohme Corp. Hiv protease inhibitors
WO2015134366A1 (en) 2014-03-06 2015-09-11 Merck Sharp & Dohme Corp. Hiv protease inhibitors
US10138255B2 (en) 2014-03-10 2018-11-27 Merck Sharp & Dohme Corp. Piperazine derivatives as HIV protease inhibitors
WO2017151922A1 (en) 2016-03-02 2017-09-08 The Board Of Regents Of The University Of Texas System Sting activating nanovaccine for immunotherapy
CN106588922B (zh) * 2017-01-17 2018-04-27 北京工业大学 二取代八氢-1,6-萘啶类化合物及其制备方法和应用
WO2019018354A1 (en) * 2017-07-18 2019-01-24 Merck Patent Gmbh ANTAGONISTS OF TLR7 / 8 AND USES THEREOF
CN109776415B (zh) * 2019-03-07 2020-11-17 福建南方制药股份有限公司 一种Roxadustat中间体的制备方法
CN115710249B (zh) * 2022-11-14 2024-11-19 广东工业大学 一种多取代异喹啉和1,6-萘啶化合物的制备方法及光电材料常见分子骨架
CN119841471B (zh) * 2025-03-24 2025-06-03 杭州汇能实业有限公司 一种热镀锌冷却循环水的处理方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5751837B2 (de) * 1973-04-05 1982-11-04
US4416884A (en) 1978-04-12 1983-11-22 Otsuka Pharmaceutical Co., Ltd. Piperazinylbenzoheterocyclic compounds
FR2632639B1 (fr) 1988-06-09 1990-10-05 Sanofi Sa Derives d'amino-4 carboxy-3 naphtyridines, leur preparation et compositions pharmaceutiques qui les contiennent
IL101860A0 (en) 1991-05-31 1992-12-30 Ici Plc Heterocyclic derivatives
US5681832A (en) * 1995-02-17 1997-10-28 The United States Of America As Represented By The Department Of Health And Human Services Aroylaniline compounds, pharmaceutical compositions, and methods of using same to inhibit viral activity
US5633362A (en) * 1995-05-12 1997-05-27 E. I. Du Pont De Nemours And Company Production of 1,3-propanediol from glycerol by recombinant bacteria expressing recombinant diol dehydratase
ES2211965T3 (es) * 1995-08-02 2004-07-16 Darwin Discovery Limited Quinolonas y su utilizacion terapeutica.
US5945431A (en) 1996-03-15 1999-08-31 Biochem Therapeutics Incorporated Cytomegalovirus inhibiting compounds
US6310211B1 (en) * 1996-09-10 2001-10-30 Pharmacia & Upjohn Company 8-hydroxy-7-substituted quinolines as anti-viral agents
AU733551B2 (en) 1996-09-25 2001-05-17 Astrazeneca Ab Qinoline derivatives inhibiting the effect of growth factors such as VEGF
US5766944A (en) * 1996-12-31 1998-06-16 Ruiz; Margaret Eileen T cell differentiation of CD34+ stem cells in cultured thymic epithelial fragments
CA2295309A1 (en) 1997-06-30 1999-01-07 Nippon Kayaku Kabushiki Kaisha Novel naphthyridine derivatives or salts thereof
YU10500A (sh) 1997-08-25 2002-10-18 Neurogen Corporation Supstituisani 4-okso-naptiridin-3-karboksamidi kao gaba moždani receptorski liganidi
GB9720052D0 (en) 1997-09-19 1997-11-19 Smithkline Beecham Plc Novel compounds
US6525042B1 (en) 1997-09-30 2003-02-25 Daiichi Pharmaceutical Co., Ltd. Sulfonyl derivatives
RU2220960C2 (ru) 1997-12-22 2004-01-10 Фармация Энд Апджон Компани 4-гидрокси-3-хинолинкарбоксамиды и гидразиды, фармацевтическая композиция и способ лечения на их основе
US6306891B1 (en) 1998-06-03 2001-10-23 Merck & Co., Inc. HIV integrase inhibitors
US6262055B1 (en) 1998-06-03 2001-07-17 Merck & Co., Inc. HIV integrase inhibitors
US6380249B1 (en) 1998-06-03 2002-04-30 Merck & Co., Inc. HIV integrase inhibitors
SE9802550D0 (sv) 1998-07-15 1998-07-15 Active Biotech Ab Quinoline derivatives
JP2003503386A (ja) 1999-06-25 2003-01-28 メルク エンド カムパニー インコーポレーテッド １−（芳香族またはヘテロ芳香族置換）−３−（ヘテロ芳香族置換）−１，３−プロパンジオン類およびそれの使用
US6730682B2 (en) 2000-07-12 2004-05-04 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
GB0017676D0 (en) 2000-07-19 2000-09-06 Angeletti P Ist Richerche Bio Inhibitors of viral polymerase
ATE430745T1 (de) * 2000-10-12 2009-05-15 Merck & Co Inc Aza- und polyaza naphthalenyl karboxamide als inhibitoren der hiv-integrase
CN1336363A (zh) 2001-07-25 2002-02-20 张元宾 乙酰磺胺酸钾的合成制备方法
AR036256A1 (es) * 2001-08-17 2004-08-25 Merck & Co Inc Sal sodica de un inhibidor de integrasa del vih, procesos para su preparacion, composiciones farmaceuticas que lo contienen y su uso para la manufactura de un medicamento
EP1427726A1 (de) 2001-08-17 2004-06-16 Merck & Co., Inc. Verfahren zur darstellung von 5-sulfonamido-8-hydroxy-1,6-naphthyridin-7-carboxamiden
DE60209381T2 (de) 2001-10-26 2006-10-05 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. N-substituierte hydroxypyrimidinoncarboxamid-hemmer der hiv-integrase
SI1441734T1 (sl) 2001-10-26 2007-08-31 Angeletti P Ist Richerche Bio Dihidropirimidin karboksamidni inhibitorji HIV-integraze
US20050165000A1 (en) * 2002-04-10 2005-07-28 Robertson Sandra K. Pharmaceutical compositions containing an hiv integrase inhibitor and a nonionic surfactant

Also Published As

Publication number Publication date
BR0114610A (pt) 2005-12-13
BG107677A (bg) 2003-11-28
US20030055071A1 (en) 2003-03-20
CN1469878A (zh) 2004-01-21
KR20030036922A (ko) 2003-05-09
EE200300145A (et) 2003-06-16
CZ20031028A3 (cs) 2003-08-13
US20050176718A1 (en) 2005-08-11
WO2002030930A3 (en) 2002-08-29
AU2002211874A1 (en) 2002-04-22
PL360944A1 (en) 2004-09-20
AR033845A1 (es) 2004-01-07
SK4322003A3 (en) 2003-09-11
CA2425440A1 (en) 2002-04-18
JP4252797B2 (ja) 2009-04-08
WO2002030931A3 (en) 2002-10-24
EA200300449A1 (ru) 2003-10-30
NO20031672D0 (no) 2003-04-11
YU27903A (sh) 2006-05-25
IL155089A0 (en) 2003-10-31
WO2002030930A2 (en) 2002-04-18
DE60138635D1 (de) 2009-06-18
WO2002030931A2 (en) 2002-04-18
HUP0302367A2 (hu) 2003-11-28
NZ525088A (en) 2004-11-26
CA2425440C (en) 2010-04-13
PE20020509A1 (es) 2002-06-20
JP2004511483A (ja) 2004-04-15
NO20031672L (no) 2003-06-05
EP1326865B1 (de) 2009-05-06
US6921759B2 (en) 2005-07-26
AU1152702A (en) 2002-04-22
IS6760A (is) 2003-03-27
MXPA03003263A (es) 2003-06-06
EP1326865A2 (de) 2003-07-16
AU2002211527B2 (en) 2006-08-24

Similar Documents

Publication Publication Date Title
DE60138635D1 (de) Aza- und polyaza naphthalenyl karboxamide als inhibitoren der hiv-integrase
DE60103976D1 (de) Pyrimidinylcarboxamiden als inhibitoren der pde4 isoenzyme
ATE435211T1 (de) Imidazolidinone als ns3-serin protease inhibitoren von hepatitis c virus
NO20021647D0 (no) Fremgangsmåte ved brukergrensesnitt hos hånd-holdte anordninger
DE60110205D1 (de) Nicotinamide benzoanellierte-heterocyclische derivate als selektive inhibitoren der pde4 isoenzyme
DE60121032D1 (de) Heterocyclische sulfonamide als inhibitoren der beta-amyloid-produktion
ATE256127T1 (de) Betacarbolinderivate als phosphodiesterase- inhibitoren
ATE370137T1 (de) 4-(6-gliedriger)-heteroaryl-acyl-pyrrolidin derivate als hcv-inhibitoren
AR028567A1 (es) Nuevos derivados de fenil-propargileter
ATE349209T1 (de) Naphthyridine derivate, ihre herstellung und ihre anwendung als phosphodiesterase isoenzyme 4 (pde4) inhibitoren
DE60305061D1 (de) 2-pyridonderivate als inhibitoren von neutrophiler elastase
NO20024159L (no) Derivater av kinolin som alfa-2 antagonister
DE60135087D1 (de) Dipeptidnitrile als inhibitoren von cathepsin k
DE60106252D1 (de) Substituierte pyprolopyridinonderivate als phosphodiesterase-inhibitoren
AR028596A1 (es) Nuevos derivados de fenilglicina
DE60121480D1 (de) Umformung von dünnwandigen Körpern
DE60110232D1 (de) Neue verwendung von lipase-inhibitoren
DE50107316D1 (de) Neue substituierte imidazotriazinone als pde ii-inhibitoren
DE60021194D1 (de) Phenylpiperazin-derivate als inhibitoren der serotonin-wiederaufnahme
ATE260274T1 (de) Furanonderivate als inhibitoren von cathepsin s
NO20022125D0 (no) Pyrrolderivater som inhibitorer for fosfodiesterase VII
AR028281A1 (es) Derivados de 2-(arilalquilamino) pirimidona y derivados de 2-(heteroaroarilalquilamino) pirimidona
DE60120940D1 (de) Pyrrolidin-derivate verwendbar als bax-inhibitoren
DE60119076D1 (de) Gebrauch von Pyrometerdaten um Oxydation festzustellen
NO20021730D0 (no) Ny formulering av mirtazapin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties